In-Vitro Toxicology/Toxicity Testing Market by Industry (Cosmetics, Pharmaceutical), Product & Services, Toxicity Endpoint & Test (Dermal Toxicity, Carcinogenicity), Method (Cellular Assays), Technology (HTS, Cell-based), Region-2020 to 2025

$3,850.00$5,850.00

AVAIL 20% DISCOUNT ON PURCHASE OF ANY REPORT
Published on: March 23, 2020
Clear
SKU: GMS-2070 Category:

The In-Vitro Toxicology Testing Market is expected to reach USD 10.2 billion by 2025, growing at a CAGR of 6.44% during the forecast period 2020-2025. The new research initiatives, mandatory preclinical safety evaluation of molecules, and growing R&D for detecting toxicity in the early stages of drug development are the primary growth drivers for this industry segment.

In-Vitro Toxicology/Toxicity Testing Market by Industry (Cosmetics, Pharmaceutical), Product & Services, Toxicity Endpoint & Test (Dermal Toxicity, Carcinogenicity), Method (Cellular Assays), Technology (HTS, Cell-based), Region-2020 to 2025 1

In-Vitro Toxicology/Toxicity Testing Market by Industry (Cosmetics, Pharmaceutical), Product & Services, Toxicity Endpoint & Test (Dermal Toxicity, Carcinogenicity), Method (Cellular Assays), Technology (HTS, Cell-based), Region-2020 to 2025 2

In-Vitro Toxicology/Toxicity Testing Market by Industry (Cosmetics, Pharmaceutical), Product & Services, Toxicity Endpoint & Test (Dermal Toxicity, Carcinogenicity), Method (Cellular Assays), Technology (HTS, Cell-based), Region-2020 to 2025 3

In-Vitro Toxicology/Toxicity Testing Market by Industry (Cosmetics, Pharmaceutical), Product & Services, Toxicity Endpoint & Test (Dermal Toxicity, Carcinogenicity), Method (Cellular Assays), Technology (HTS, Cell-based), Region-2020 to 2025 4

In-Vitro Toxicology/Toxicity Testing Market by Industry (Cosmetics, Pharmaceutical), Product & Services, Toxicity Endpoint & Test (Dermal Toxicity, Carcinogenicity), Method (Cellular Assays), Technology (HTS, Cell-based), Region-2020 to 2025 5

In-Vitro Toxicology/Toxicity Testing Market by Industry (Cosmetics, Pharmaceutical), Product & Services, Toxicity Endpoint & Test (Dermal Toxicity, Carcinogenicity), Method (Cellular Assays), Technology (HTS, Cell-based), Region-2020 to 2025 6

In-Vitro Toxicology/Toxicity Testing Market by Industry (Cosmetics, Pharmaceutical), Product & Services, Toxicity Endpoint & Test (Dermal Toxicity, Carcinogenicity), Method (Cellular Assays), Technology (HTS, Cell-based), Region-2020 to 2025 7

In-Vitro Toxicology/Toxicity Testing Market by Industry (Cosmetics, Pharmaceutical), Product & Services, Toxicity Endpoint & Test (Dermal Toxicity, Carcinogenicity), Method (Cellular Assays), Technology (HTS, Cell-based), Region-2020 to 2025 8

1 Global In-Vitro Toxicology/Toxicity Testing Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global In-Vitro Toxicology/Toxicity Testing Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global In-Vitro Toxicology/Toxicity Testing Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global In-Vitro Toxicology/Toxicity Testing Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global In-Vitro Toxicology/Toxicity Testing Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.1.1 Increasing R&D Expenditure to Detect Toxicity at an Early Stage
6.2.1.2 Rising opposition to animal testing
6.2.1.3 Increasing Drug Discovery and Innovation & Modernization in the In Vitro Toxicity Testing Market
6.2.2 Challenges
6.2.2.1 Dearth of Skilled Professionals
6.2.2.2 Failure to Establish Intricacies of In Vivo Conditions Through In Vitro
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global In-Vitro Toxicology/Toxicity Testing Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global In-Vitro Toxicology/Toxicity Testing Market – By Technology (Market Size – &
million/billion)
8.1 Cell Culture Technologies
8.2 Cellular Imaging Technologies
8.3 Toxicogenomics
8.4 High-Throughput Technologies

9 Global In-Vitro Toxicology/Toxicity Testing Market – By Method
9.1 Ex Vivo Based
9.2 Biochemical Assay Based
9.3 Cellular Assay Based
9.4 In-Silico Based

10 Global In-Vitro Toxicology/Toxicity Testing Market – By Industry
10.1 Pharmaceutical and Biopharmaceutical Industry
10.2 Cosmetics and Household Products Industry
10.3 Food Industry
10.4 Chemical Industry
10.5 Others

11 Global In-Vitro Toxicology/Toxicity Testing Market – By Geography (Market Size – &
million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa

12 Global In-Vitro Toxicology/Toxicity Testing Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships

13 Global In-Vitro Toxicology/Toxicity Testing Market Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 SGS S.A.
13.3 Covance, Inc.
13.4 Bio-Rad Laboratories, Inc.
13.5 Qiagen N.V.
13.6 GE Healthcare
13.7 Merck KGaA
13.8 Eurofins Scientific Se
13.9 Charles River Laboratories International, Inc.
13.10 Catalent, Inc.
13.11 Thermo Fisher Scientific, Inc
13.12 Company 11 & more

14 Global In-Vitro Toxicology/Toxicity Testing Market – Appendix
14.1 Sources
14.2 Abbreviations